Publication:
Distinguishing Meningioma From Metastasis of Prostate Cancer on 68Ga-PSMA PET/CT

Simple item page
dc.contributor.authorsFilizoglu N., Oksuzoglu K., Ozguven S.
dc.date.accessioned2022-03-15T02:16:22Z
dc.date.accessioned2026-01-11T09:12:16Z
dc.date.available2022-03-15T02:16:22Z
dc.date.issued2021
dc.description.abstractABSTRACT: Meningiomas are typically benign and the most common primary brain tumors. They are usually diagnosed based on their characteristic appearance on both MRI and CT. Meningiomas can easily be misdiagnosed as metastasis of prostate cancer due to their high 68Ga-PSMA uptake on 68Ga-PSMA PET/CT. We present a case of a metastatic prostate adenocarcinoma with PSMA-avid lesion in the right frontal lobe on 68Ga-PSMA PET/CT. Later, MRI confirmed the brain lesion as meningioma. Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
dc.identifier.doi10.1097/RLU.0000000000003629
dc.identifier.issn15360229
dc.identifier.pubmed34606488
dc.identifier.urihttps://hdl.handle.net/11424/248216
dc.language.isoeng
dc.publisherNLM (Medline)
dc.relation.ispartofClinical nuclear medicine
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleDistinguishing Meningioma From Metastasis of Prostate Cancer on 68Ga-PSMA PET/CT
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPagee555
oaire.citation.issue11
oaire.citation.startPagee553
oaire.citation.titleClinical nuclear medicine
oaire.citation.volume46

Files

Collections

Araştırma Çıktıları